Navigation Links
Special issue of Gut Microbes on Helicobacter pylori
Date:11/18/2013

A special issue on Helicobacter pylori has been published by Landes Bioscience (Austin, TX USA). The articles contained in this special issue of the journal Gut Microbes have been authored by world-class investigators and provide new insights into the pathophysiology, diagnosis, prevention, and treatment of this microbe.

Helicobacter pylori is a gram-negative, microaerophilic bacterium found in the stomach. Identified in the early 1980s, it was shown to be present in patients with chronic gastritis and gastric ulcers, conditions that were not previously believed to have a microbial cause. It is also linked to the development of duodenal ulcers and stomach cancer. However, in over 80% of carriers, H. pylori does not cause symptoms and it has been suggested that the bacterium may play an important role in the natural stomach ecology. H. pylori is the most common bacterial infection worldwide, with more than half of the world's population harboring the bacterium in the upper gastrointestinal tract. While incidence is decreasing in Western countries, H. pylori infection is highly prevalent in developing countries. In the absence of targeted antimicrobial therapy, colonization typically lasts for decades.

Dr Richard Peek from Vanderbilt-Ingram Cancer Center and Cancer Biology (Nashville, TN USA) has worked with the editorial team of Gut Microbes to organize this special issue on H. pylori. Papers in the issue discuss the role of childhood infection in the sequelae of H. pylori disease (Guillermo Perez-Perez), how glyco-conjugates promote virulence of H. pylori (M Stephen Trent), interplay of various H. pylori factors with host protein receptors (Steffen Backert), the role of chronic inflammation and oxidative stress in H. pylori induced gastric cancer (Keith T Wilson), diet, microbial virulence, and H. pylori induced gastric cancer (Timothy L Cover), consequences of H. pylori infection in children in developing countries (Jean E Crabtree), role of the gastrointestinal microbiome in H. pylori pathogenesis (James G Fox), biomarkers of H. pylori associated gastric cancer (Jay V Solnick), H. pylori therapies in light of evolving resistance (Francis Mgraud), benefits of H. pylori treatment in childhood (Karen J Goodman), vaccination against H. pylori (Steven J Czinn), and a study investigating the influence of H. pylori on hepatitis C virus-associated liver cancer.

In an accompanying editorial, Dr Peek highlights the importance of understanding the relationship between H. pylori infection and carcinogenesis. He writes, "Delineation of bacterial, host, and environmental mediators that augment gastric cancer risk has profound ramifications for both physicians and biomedical researchers, as such findings will not only focus prevention approaches that target H. pylori-infected human populations at increased risk for stomach cancer, but will also provide mechanistic insights into inflammatory carcinomas that develop beyond the gastric niche." The full issue is available at the following link: http://www.landesbioscience.com/journals/gutmicrobes/toc/volume/4/issue/6/


'/>"/>

Contact: Andrew Thompson
andrew@landesbioscience.com
Landes Bioscience
Source:Eurekalert

Related biology news :

1. Walgreens Mike Ellis Named First President of National Association of Specialty Pharmacy (NASP)
2. Genetics in Medicine publishes special issue dedicated to genomics in electronic health records
3. Journal of Spinal Cord Medicine publishes special issue on assistive technology
4. RNA-interference pesticides will need special safety testing
5. CARE Pharmacies Joins National Association of Specialty Pharmacy (NASP) as a Founding Corporate Member
6. AegisCare Offers Specialized Home Health Care for Dementia and Alzheimers Patients
7. NASP and ASCP Discuss Future of Specialty Pharmacy in Aging Market at Upcoming ASCP Conference
8. More food and greener farming with specialised transporters for plants
9. Geosphere adds 2 new special issue themes
10. Beckers Spine Review Releases List of 50 Spine Surgeons & Specialists Researching Biologics for Spine Treatments
11. Biological wires carry electricity thanks to special amino acids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... a global clinical research organization (CRO), announces the launch of Shadow, ... 2017. Shadow is designed to assist medical writers and biometrics teams ... European Medicines Agency (EMA) in meeting the requirements for de-identifying clinical ... ... Tom ...
(Date:6/30/2017)... Today, American Trucking Associations announced Seeing ... and eye tracking software, became the newest member ... "Artificial intelligence and advanced sensing algorithms ... driver,s attentiveness levels while on the road.  Drivers ... fatigue and prevent potential accidents, which could lead ...
(Date:5/16/2017)... 16, 2017  Veratad Technologies, LLC ( www.veratad.com ), ... and identity verification solutions, announced today they will participate ... May 15 thru May 17, 2017, in ... Trade Center. Identity impacts the lives ... today,s quickly evolving digital world, defining identity is critical ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced that ... SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 ... cross the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... ... 10, 2017 , ... Dr. Bob Harman, founder and CEO of VetStem ... The event entitled “Stem Cells and Their Regenerative Powers,” was held ... Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief ...
(Date:10/10/2017)... 2017 SomaGenics announced the receipt of a ... RealSeq®-SC (Single Cell), expected to be the first commercially ... microRNAs) from single cells using NGS methods. The NIH,s ... accelerate development of approaches to analyze the heterogeneity of ... techniques for measuring levels of mRNAs in individual cells ...
Breaking Biology Technology: